BRAF and cancer: Regarding the capability of KRAS and BRAF mutant tumors to create an immunosuppressive microenvironment by interfering with the cancer-immunity cycle, various studies have shown that MEKi can restore an immune stimulatory and anti-tumorigenic microenvironment.